Xi'an Janssen Pharmaceutical Co., Ltd. was established on October 22, 1985. It is a joint venture between Shaanxi Pharmaceutical Corporation, Shaanxi Hanjiang Pharmaceutical Co., Ltd., China National Pharmaceutical Industry Corporation and China National Pharmaceutical Foreign Trade Corporation. It is a modern pharmaceutical company jointly established by the Belgian Janssen Pharmaceutical Company, a subsidiary of Johnson & Johnson of the United States, with a total investment of 290 million yuan.
Xi'an Janssen produces and sells more than 20 kinds of patented drugs, covering the fields of mycology, gastroenterology, psychiatry, neurology, anesthesia and analgesia, allergy, anti-infection and other fields.
Xi'an Janssen is headquartered in the Central Business District (CBD) of Beijing where foreign-funded enterprises gather. The factory is located in Xi'an and has more than 20 offices across the country. Currently, Xi'an Janssen has 1,500 outstanding employees.
Xi'an Yangsen Factory is located in the ancient city of Xi'an, covering an area of ??170 acres and a construction area of ??35,620 square meters. Both production and management meet the requirements of the World Health Organization (WHO) and the pharmaceutical production quality management regulations of China and the European Union. (GMP) standards and adopt internationally accepted modern enterprise management systems for operation and management.
Xi'an Janssen Pharmaceutical Co., Ltd. has the most advanced production facilities and testing equipment. From raw materials entering the factory, manufacturing, packaging to finished product inspection and delivery, strict quality supervision and control are carried out in all links to ensure the quality of medicines.
In 1997, Xi'an Janssen was the first Chinese pharmaceutical company to pass the national pharmaceutical GMP certification. Since 1994, Xi'an Janssen has implemented SOQ (Sign of Quality) activities, continuously improved product quality and process management, and continued to provide customers with quality services to maintain the company's best competitiveness. In 1998, Xi'an Janssen won the Johnson & Johnson Group's Seal of Quality (SOQ) Bronze Award. In 1999, it obtained the national ISO9002 quality management system certification. In 2000, Xi'an Janssen invested nearly 10 million US dollars to transform the factory's production environment, making Xi'an Janssen's comprehensive indicators in terms of production environment and product quality reach the international advanced level; in the same year, it passed the national OHSMS/OHSAS18001 occupational safety and health management System certification.
In October 2004, Xi'an Janssen successfully passed the audit of the EU GMP Audit Office and obtained certification for both solid production and non-solid production. It indicates that our factories, equipment, environment, personnel, document system and quality management system fully comply with European GMP standards. The products produced under such a system can fully meet the European market's pharmaceutical quality requirements.
Xi'an Janssen regards environmental protection as its sacred duty, minimizing the impact on the environment in all products, processes, technologies and equipment, preventing environmental pollution, and rationally utilizing resources. In 1998, Xi'an Janssen obtained the ISO14001 environmental management system certification certificate issued by the China Quality Certification Commission, becoming the first Johnson & Johnson Group company in the Asia-Pacific region to obtain this certification. As a subsidiary of Johnson & Johnson, Xi'an Janssen implements its "global environmental policy" and won the Honorable Mention in the Johnson & Johnson Global Environmental Performance Competition in 1999; in 2001, Xi'an Janssen again won the Johnson & Johnson Award for its outstanding performance in environmental protection. Honorary Award for the Group's Global Environmental Performance Leadership Competition.
In 2004, it won the first "Guangming Charity Award"
In 2004, it was named "China's Most Culturally Valuable Brand"
In 2004, it was selected into Xi'an The city's "Top Ten Industrial Enterprises with Outstanding Contributions"
In 2003, it won the title of "National Advanced Unit for After-sales Service of Famous and High-Quality Products"
In 2002, it was selected into "Fortune" magazine (Chinese version) "China's Most Admired Foreign-Funded Companies" and "China's Top Ten Most Socially Responsible Foreign-Funded Companies"
In 2002, it was selected as one of the "Popular Employers in the Eyes of Human Resources Managers" by Fortune magazine (Chinese version). Xi'an Janssen is the only pharmaceutical company selected
gt;top
In 2001, the Red Cross Society of China awarded Xi'an Janssen the "Humanitarian Service" Medal in recognition of Xi'an Janssen's contribution to promoting For its contribution to the expansion of the "China Hematopoietic Stem Cell Donor Database"
In 2001, Xi'an Yangsen won the "Practice Award" in the "Chinese Corporate Culture Innovation Selection" event sponsored by the China Corporate Culture Research Association "
In 2001, Xi'an Janssen once again won the Johnson & Johnson Global Environmental Performance Leadership Award for its outstanding performance in environmental protection.
In 2000, it won the "Happiness Project" organizing committee "Outstanding Contribution Award" issued by the Association
In 2000, it passed the national OHSMS/OHSAS18001 occupational safety and health management system certification
In 2000, the former chairman and CEO of Johnson & Johnson Ralph Larsen received the "Marco Polo" China Contribution Award from China's State Administration of Foreign Experts Affairs and the American Volunteer Donor Association
In 1999, he was rated as China's One of the "Top Ten Most Admired Foreign Companies", including:
Top Ten Overall Most Admired Companies
Top Ten Companies Most Admired for Products and Service Quality
p>Top ten companies that best demonstrate good social ethics
Top ten most reliable partners or suppliers
In 1999, obtained the national ISO9002 quality system certification
Top ten most reliable partners or suppliers
p>
In 1999, it won the Honorary Award in the Johnson & Johnson Global Environmental Performance Competition
gt;gt;top
In 1998, it was awarded the Award by the Environmental Management System Audit Center of the State Environmental Protection Administration ISO14001 Environmental Management System Certification
In 1998, it won the Johnson & Johnson Group's global "Mark of Quality" SOQ Bronze Award
In 1997, it won the No. 007 GMP issued by the China Pharmaceutical Certification Commission. Certification certificate
In 1997, the sales revenue of China's chemical pharmaceutical preparation manufacturing industry ranked first
In 1996, the top 50 pharmaceutical industries in China ranked first
In 1995 , ranked first in the first national top ten best pharmaceutical joint ventures competition
In 1994, ranked second in the eighth national top ten best joint ventures
In 1994, China 500 The pharmaceutical manufacturing industry ranked second among the industrial enterprises with the best economic benefits
In 1994, the largest pharmaceutical manufacturing enterprise in China ranked ninth
In 1994, it ranked among the outstanding enterprises in the national pharmaceutical industry
p>
gt;gt;top
In 1993, ranked first in the 7th National Top Ten Best Joint Ventures
In 1993, it was rated as Ranked No. 1 among the “Top Ten” Enterprises in Industrial Pollution Prevention and Control in Shaanxi Province
In 1993, National Environmental Protection Advanced Unit
In 1993, Best Credit Customer for Foreign-Invested Enterprise Loans
In 1992, ranked first among the top ten profit and tax enterprises in the pharmaceutical industry
In 1992, ranked first in the 6th National Top Ten Best Joint Ventures Competition
In 1992, China Ranked fourth among the top ten foreign-invested enterprises with high profits and taxes per capita
In 1992, one of the 100 advanced environmental protection units in the country
In 1991, ranked among the top ten best joint ventures in the fifth session of the country Four
1991, China
Ranked first among the 50 best economic enterprises in the pharmaceutical industry
In 1991, ranked sixth among the 50 largest enterprises in the Chinese pharmaceutical industry
In 1991, ranked among the 500 best economic enterprises in the country No. 1 Chinese medicine enterprise among benefit industrial enterprises
In 1990, the nation's advanced pharmaceutical packaging management enterprise
Eight factors of Xi'an Janssen's success ("Shaanxi Daily" 2005.10.24)
Xi'an Janssen is one of the earliest joint ventures in my country and one of the first pioneers to devote itself to the development of the western region. After 20 years of development, Xi'an Janssen has become a leading enterprise in China's pharmaceutical industry and a model for the development and opening up of the western region.
The development history and achievements of Xi'an Janssen have attracted widespread attention from all walks of life, and everyone is exploring the factors behind Xi'an Janssen's success. We ourselves are also constantly analyzing and summarizing, in order to build on the past and open up the future, achieve scientific development, and continue to contribute to the development of the western region. We have summarized Xi'an Yangsen's eight major success factors, including external factors and internal factors. To sum up, only by persisting in reform and opening up can development prosper.
First, seize the opportunity of reform and opening up. The successive leadership teams of the Provincial Party Committee, Provincial Government and Xi'an Municipal Party Committee and Municipal Government have been unswervingly implementing the policy of reform and opening up. Their courage and sincere and pragmatic style have provided guarantees for the development of foreign-funded enterprises and created a good environment and conditions. .
In the 20-year development history of Xi'an Janssen, it has always received the care of leaders at the provincial and municipal levels. They have visited the company many times to inspect and provide timely instructions and solutions to the problems and difficulties we reported. This is not because the leaders have a preference for Xi'an Yangsen, but a reflection of the determination and sincerity of the provincial and municipal governments in attracting investment.
Second, Shaanxi is home to outstanding people and has abundant energy and talent advantages.
Shaanxi is a province of science and education. In addition, it has a profound history and cultural heritage, and a superior humanistic and scientific and technological environment. Xi'an Yangsen absorbs outstanding talents from here every year. Xi'an is our talent base, and through Xi'an Janssen's training, we have sent a large number of outstanding talents to the pharmaceutical industry.
Shaanxi Province is rich in energy reserves. Eight hundred miles away from Qinchuan, the weather is smooth. When starting a business here, we feel the advantages of time, location, and people. We have never been troubled by energy supply.
Third, the shareholders of both joint ventures should cooperate sincerely. Both the Belgian Janssen and the four Chinese shareholders agree that Xi'an Janssen is a long-term cooperation project between the China and Belgium joint ventures. They are all working to establish an international-level joint venture pharmaceutical company in the same place - this ** *Invest and contribute for the same purpose, regardless of short-term gains and losses.
Fourth, Xi’an Janssen has high-quality products that are suitable for China’s national conditions and clinical needs.
Xi’an Janssen has been committed to selectively introducing high-quality patented products from Janssen of Belgium and Johnson & Johnson of the United States to China to benefit Chinese patients, and to bring the latest pharmaceutical development information to Chinese medical workers , providing scientific basis and guidance for doctors and patients to use medicine scientifically. Our high-quality products and scientific promotion model have won us the trust of doctors and patients, and the recognition of colleagues in the industry.
Fifth, Xi'an Janssen has world-class production facilities. During the Sino-Belgian joint venture negotiations in 1983, China listed the introduction of advanced management technology in the pharmaceutical industry from developed countries in the world as the primary condition and wrote it into the agreement. The production workshop was designed and constructed in strict accordance with the Belgian Janssen GMP standards at that time. This enabled Xi'an Janssen to build on a high starting point and high level from the beginning. In 1997, Xi'an Janssen took the lead in passing my country's national GMP certification. In 2000, Xi'an Janssen invested in launching a continuous GMP transformation plan. This one-year transformation plan has basically enabled Xi'an Janssen to reach the GMP level of Europe and the United States. In October 2004, Xi'an Janssen successfully passed the EU GMP certification.
Sixth, Xi'an Janssen has a strong corporate culture that combines the essence of Chinese and Western cultures, that is, "the creed is the foundation and the goal is perfection."
Xi'an Janssen's corporate culture, which combines the essence of Chinese and Western cultures, is willing to be accepted by Chinese employees, thus forming a huge cohesion and becoming the cornerstone of Xi'an Janssen's success.
Seventh, Xi’an Yangsen has a strong talent advantage. Xi'an Janssen has gathered a group of outstanding employees with the same values. Among them, there are both local elites and international talents. They are both professional and dedicated. This multi-cultural team has strong leadership and creativity. The personal dedication of managers at all levels is particularly valuable.
Eighth, be sincere and repay the society. Xi'an Janssen has a long-term commitment to the health of the Chinese people. Therefore, giving back to the society is a philosophy that Xi'an Janssen practices in practice. The 20 years of Xi'an Janssen's development have also been 20 years of continuous dedication to society. Xi'an Janssen's total investment in supporting the development of China's health education and public welfare charities amounts to hundreds of millions of yuan. Huge public investment has won praise and praise from society.
Looking back on the past, we have achieved fruitful results, and looking forward to the future, we are full of confidence. Xi'an Janssen is currently implementing two major development strategies.
First of all, "products guide the future" is Xi'an Janssen's future development strategy. From 2004 to 2014, in these 10 years, Xi'an Janssen plans to introduce and launch more than 20 high-tech new products, involving cardiovascular and cerebrovascular, cancer, pain management, central nervous system, men's health and women's health and other fields. According to Xi'an Janssen's plan, sales of new products will account for 29% of total sales. New products and new fields are the driving force for Xi'an Janssen's development and the key to Xi'an Janssen's future success in the market!
Second, establish a first-class pharmaceutical production base in the Asia-Pacific region and even the world. Xi'an Janssen will continue to invest in improving Xi'an Janssen's GMP level. On the basis of passing EU GMP certification, it will speed up the US FDA certification work so that Xi'an Janssen's products will become synonymous with "high quality" and sell well around the world.
Currently, Xi'an Janssen is entering a new and rapid development period. Implementing the scientific outlook on development, Xi'an Janssen has formulated a new mission and vision, that is: under the guidance of the "Creed", we will provide innovative, international-level drugs and sincerely cooperate with people from all walks of life in domestic medicine and health,* **Together we promote the noble cause of saving human lives and improving the quality of life; we continue to maintain our leading position in China's pharmaceutical industry. All employees of Xi'an Janssen are working hard for this common mission and vision. Xi'an Yangsen firmly believes that he can continue to write a more glorious chapter in the next two decades.
(The author is the deputy general manager of Shaanxi Pharmaceutical Corporation and the chairman of Xi’an Janssen Company)